Outcomes | Number (%) |
Status at 1 year | |
Discharged home | 76/94 (81) |
Died | 15/94 (16) |
Remained inpatient | 1/94 (1.1) |
Not known | 2/94 (2.1) |
Age of discharge home (days) | 143 (117–185) |
CGA of discharge home (weeks) | 46.6 (43–52.9) |
Age of death (days) | 159 (105–182) |
CGA of death (weeks) | 49.6 (42.6–52.6) |
Respiratory support at discharge | |
Air | 8/79 (10.1) |
Low-flow oxygen | 60/79 (75.9) |
Long-term ventilation (ventilation, CPAP, high flow) | 7/79 (8.9) |
Not known | 4/79 (5.1) |
Comorbidities | |
Retinopathy of prematurity requiring treatment | 26/94 (27.7) |
Laser | 20/94 (21.3) |
Avastin | 3/94 (3.2) |
Both | 3/94 (3.2) |
Periventricular leukomalacia | 7/94 (7.4) |
Ventriculoperitoneal shunt inserted | 5/94 (5.3) |
Gastrostomy inserted | 7/94 (7.4) |
Tracheostomy | 5/94 (5.3) |
Neurological assessment at 1 year | |
Normal | 37/60 (61.7) |
Minor concerns | 10/60 (16.7) |
Major concerns | 13/60 (21.7) |
Death or long-term ventilation (LTV) | 22/94 (23.4) |
Death or major neurodevelopmental impairment (NDI) | 28/75 (37.3)* |
Death or major morbidity (LTV, major NDI or readmission for respiratory support within 1st year) | 42/94 (44.7) |
Data presented as number (%) or median (IQR).
*Outcomes reported for infants with complete data only.
CGA, corrected gestational age; CPAP, continuous positive airway pressure.